α-Synuclein in Parkinson’s disease: causal or bystander?
- 25 June 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 126 (7), 815-840
- https://doi.org/10.1007/s00702-019-02025-9
Abstract
Parkinson’s disease (PD) comprises a spectrum of disorders with differing subtypes, the vast majority of which share Lewy bodies (LB) as a characteristic pathological hallmark. The process(es) underlying LB generation and its causal trigger molecules are not yet fully understood. α-Synuclein (α-syn) is a major component of LB and SNCA gene missense mutations or duplications/triplications are causal for rare hereditary forms of PD. As typical sporadic PD is associated with LB pathology, a factor of major importance is the study of the α-syn protein and its pathology. α-Syn pathology is, however, also evident in multiple system atrophy (MSA) and Lewy body disease (LBD), making it non-specific for PD. In addition, there is an overlap of these α-synucleinopathies with other protein-misfolding diseases. It has been proven that α-syn, phosphorylated tau protein (pτ), amyloid beta (Aβ) and other proteins show synergistic effects in the underlying pathogenic mechanisms. Multiple cell death mechanisms can induce pathological protein-cascades, but this can also be a reverse process. This holds true for the early phases of the disease process and especially for the progression of PD. In conclusion, while rare SNCA gene mutations are causal for a minority of familial PD patients, in sporadic PD (where common SNCA polymorphisms are the most consistent genetic risk factor across populations worldwide, accounting for 95% of PD patients) α-syn pathology is an important feature. Conversely, with regard to the etiopathogenesis of α-synucleinopathies PD, MSA and LBD, α-syn is rather a bystander contributing to multiple neurodegenerative processes, which overlap in their composition and individual strength. Therapeutic developments aiming to impact on α-syn pathology should take this fact into consideration.Keywords
This publication has 255 references indexed in Scilit:
- Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of NeuroprotectionFrontiers in Neurology, 2013
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunctionNeuroscience, 2011
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionAnnals of Neurology, 2010
- The N-Terminus of the Intrinsically Disordered Protein α-Synuclein Triggers Membrane Binding and Helix FoldingBiophysical Journal, 2010
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Structural characterization of α‐synuclein in an aggregation prone stateProtein Science, 2009
- The First N-terminal Amino Acids of α-Synuclein Are Essential for α-Helical Structure Formation In Vitro and Membrane Binding in YeastJournal of Molecular Biology, 2009
- Synuclein activates microglia in a model of Parkinson's diseaseNeurobiology of Aging, 2008
- Brain proteasomal function in sporadic Parkinson's disease and related disordersAnnals of Neurology, 2002